Yinming Hu

485 total citations
12 papers, 407 citations indexed

About

Yinming Hu is a scholar working on Complementary and alternative medicine, Molecular Biology and Neurology. According to data from OpenAlex, Yinming Hu has authored 12 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Complementary and alternative medicine, 3 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in Yinming Hu's work include Berberine and alkaloids research (2 papers), Cholesterol and Lipid Metabolism (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Yinming Hu is often cited by papers focused on Berberine and alkaloids research (2 papers), Cholesterol and Lipid Metabolism (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Yinming Hu collaborates with scholars based in China and Australia. Yinming Hu's co-authors include Zhengquan Su, Weijian Bei, Jiao Guo, Jiao Guo, Tao Yi, Wei He, Tao Yi, Hongliang Zhang, Shuo Wan and Xuguang Hu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Journal of Ethnopharmacology.

In The Last Decade

Yinming Hu

12 papers receiving 402 citations

Peers

Yinming Hu
Yinming Hu
Citations per year, relative to Yinming Hu Yinming Hu (= 1×) peers Paul-Mihai Boarescu

Countries citing papers authored by Yinming Hu

Since Specialization
Citations

This map shows the geographic impact of Yinming Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinming Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinming Hu more than expected).

Fields of papers citing papers by Yinming Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinming Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinming Hu. The network helps show where Yinming Hu may publish in the future.

Co-authorship network of co-authors of Yinming Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yinming Hu. A scholar is included among the top collaborators of Yinming Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinming Hu. Yinming Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Guo, Caijuan, Hong Wang, Wenyi Liang, et al.. (2020). Bilobalide reversibly modulates blood-brain barrier permeability through promoting adenosine A1 receptor-mediated phosphorylation of actin-binding proteins. Biochemical and Biophysical Research Communications. 526(4). 1077–1084. 16 indexed citations
2.
Liang, Wenyi, Wei Xu, Jing Zhu, et al.. (2019). Ginkgo biloba extract improves brain uptake of ginsenosides by increasing blood-brain barrier permeability via activating A1 adenosine receptor signaling pathway. Journal of Ethnopharmacology. 246. 112243–112243. 36 indexed citations
3.
Zhang, Min, et al.. (2019). [Analysis of constituents from different parts of Callicarpa nudiflora by UPLC-Q-TOF-MS/MS].. PubMed. 44(21). 4661–4669. 5 indexed citations
4.
Bei, Weijian, Yujiao Wang, Jianmei Chen, et al.. (2019). Chinese Medicine FTZ Recipe Protects against High-Glucose-Induced Beta Cell Injury through Alleviating Oxidative Stress. Evidence-based Complementary and Alternative Medicine. 2019. 1–14. 18 indexed citations
5.
Feng, Shixiu, Min Zhang, Jing Xu, & Yinming Hu. (2016). Prisconnatanones A, a cytotoxic naphthoquinone from Prismatomeris connata, suppresses the proliferation of human laryngocarcinoma HEp-2 cells in vitro. Natural Product Research. 30(24). 2840–2844. 5 indexed citations
6.
Wang, Laiyou, et al.. (2014). Potential synergistic effects of Chinese herbal prescription FTZ components detected in blood towards hepatic lipid-modulating targets. Complementary Therapies in Medicine. 22(5). 887–893. 12 indexed citations
7.
Yi, Tao, et al.. (2013). Preparation of Chitosan and Water-Soluble Chitosan Microspheres via Spray-Drying Method to Lower Blood Lipids in Rats Fed with High-Fat Diets. International Journal of Molecular Sciences. 14(2). 4174–4184. 49 indexed citations
8.
Cao, Yang, Weijian Bei, Yinming Hu, et al.. (2012). Hypocholesterolemia of Rhizoma Coptidis alkaloids is related to the bile acid by up-regulated CYP7A1 in hyperlipidemic rats. Phytomedicine. 19(8-9). 686–692. 53 indexed citations
9.
Guo, Jiao, Weijian Bei, Yinming Hu, et al.. (2011). A new TCM formula FTZ lowers serum cholesterol by regulating HMG-CoA reductase and CYP7A1 in hyperlipidemic rats. Journal of Ethnopharmacology. 135(2). 299–307. 73 indexed citations
10.
Zhang, Hongliang, Tao Yi, Jiao Guo, Yinming Hu, & Zhengquan Su. (2011). Hypolipidemic effects of chitosan nanoparticles in hyperlipidemia rats induced by high fat diet. International Immunopharmacology. 11(4). 457–461. 55 indexed citations
11.
Yi, Tao, et al.. (2010). Water-Soluble Chitosan Nanoparticles Inhibit Hypercholesterolemia Induced by Feeding a High-Fat Diet in Male Sprague-Dawley Rats. Journal of Nanomaterials. 2011. 1–5. 34 indexed citations
12.
Bei, Weijian, Linquan Zang, Jiao Guo, et al.. (2009). Neuroprotective effects of a standardized flavonoid extract from Diospyros kaki leaves. Journal of Ethnopharmacology. 126(1). 134–142. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026